We are live on !
Find out more
Fieldpoint Private Securities Portfolio holdings
AUM
$344M
Turnover
18.8%
1-Year Est. Return
7.21%
This Fund
S&P 500
This Quarter Est. Return
-12.46%
1 Year Est. Return
-7.21%
3 Year Est. Return
+47.17%
5 Year Est. Return
+78.97%
10 Year Est. Return
–
AUM
$344M
AUM Growth
-$141M
(-29%)
Cap. Flow
-$78.3M
Cap. Flow % of AUM
Cap. Flow %
-22.73%
Top 10 Holdings %
Top 10 Hldgs %
23.05%
Holding
1,793
New
93
Increased
202
Reduced
1,081
Closed
244
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares International Select Dividend ETF
IDV
|
+$7M |
| 2 |
WisdomTree US MidCap Dividend Fund
DON
|
+$3.77M |
| 3 |
iShares Select Dividend ETF
DVY
|
+$2.11M |
| 4 |
WisdomTree US SmallCap Dividend Fund
DES
|
+$1.77M |
| 5 |
Broadstone Net Lease
BNL
|
+$1.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Dividend Appreciation ETF
VIG
|
+$3.61M |
| 2 |
Microsoft
MSFT
|
+$3.38M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$3.02M |
| 4 |
Apple
AAPL
|
+$2.99M |
| 5 |
UnitedHealth
UNH
|
+$2.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 42.41% |
| 2 | Technology | 15.14% |
| 3 | Financials | 9.93% |
| 4 | Healthcare | 9.62% |
| 5 | Industrials | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Moderna
MRNA
$107B
| $18K | 0.01% |
124
-90
| -42% | -$12.9K |
2021 Q2
4 quarters
|
|
627
NatWest
NWG
$63.6B
| $18K | 0.01% |
3,106
-1,973
| -39% | -$11.8K |
2020 Q4
6 quarters
|
|
628
Royal Bank of Canada
RY
$283B
| $18K | 0.01% |
183
-340
| -65% | -$34.8K |
2021 Q1
5 quarters
|
|
629
Shinhan Financial Group
SHG
$30B
| $18K | 0.01% |
630
-1,095
| -63% | -$35.6K |
2020 Q4
6 quarters
|
|
630
Xcel Energy
XEL
$51.5B
| $18K | 0.01% |
250
-79
| -24% | -$5.75K |
2020 Q4
6 quarters
|
|
631
Core Natural Resources Inc
CNR
$4.01B
| $18K | 0.01% |
360
-695
| -66% | -$33.8K |
2020 Q4
6 quarters
|
|
632
DELISTED
Orange
ORAN
| $18K | 0.01% |
1,495
-4,580
| -75% | -$54.9K |
2020 Q4
6 quarters
|
|
633
Aegon
AEG
$12.5B
| $17K | ﹤0.01% |
3,930
-6,692
| -63% | -$33.2K |
2020 Q4
6 quarters
|
|
634
Marvell Technology
MRVL
$139B
| $17K | ﹤0.01% |
396
+96
| +32% | +$5.44K |
2020 Q4
6 quarters
|
|
635
Murphy Oil
MUR
$4.95B
| $17K | ﹤0.01% |
558
+145
| +35% | +$5.59K |
2020 Q4
6 quarters
|
|
636
Petrobras
PBR
$118B
| $17K | ﹤0.01% |
1,470
-6,547
| -82% | -$90.6K |
2020 Q4
6 quarters
|
|
637
Repligen
RGEN
$11.4B
| $17K | ﹤0.01% |
105
-174
| -62% | -$27.5K |
2020 Q4
6 quarters
|
|
638
SiriusXM
SIRI
$11B
| $17K | ﹤0.01% |
276
| – | – |
2020 Q4
6 quarters
|
|
639
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$152B
| $17K | ﹤0.01% |
2,863
-11,294
| -80% | -$68.2K |
2020 Q2
8 quarters
|
|
640
Steel Dynamics
STLD
$32.4B
| $17K | ﹤0.01% |
255
-355
| -58% | -$28.4K |
2020 Q4
6 quarters
|
|
641
Brown & Brown
BRO
$23.6B
| $16K | ﹤0.01% |
273
-155
| -36% | -$9.5K |
2020 Q4
6 quarters
|
|
642
Carlisle Companies
CSL
$15.3B
| $16K | ﹤0.01% |
66
-85
| -56% | -$21.2K |
2020 Q4
6 quarters
|
|
643
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.44B
| $16K | ﹤0.01% |
454
-6,546
| -94% | -$240K |
2021 Q2
4 quarters
|
|
644
Exponent
EXPO
$4.06B
| $16K | ﹤0.01% |
175
-290
| -62% | -$27.3K |
2020 Q4
6 quarters
|
|
645
Fifth Third Bancorp
FITB
$49.1B
| $16K | ﹤0.01% |
480
+156
| +48% | +$5.86K |
2020 Q4
6 quarters
|
|
646
iShares MBS ETF
MBB
$35.9B
| $16K | ﹤0.01% |
+162
| New | +$15.9K |
2022 Q2
0 quarters
|
|
647
Bio-Techne
TECH
$11.4B
| $16K | ﹤0.01% |
180
-300
| -63% | -$28.1K |
2020 Q4
6 quarters
|
|
648
Aecom
ACM
$9.04B
| $15K | ﹤0.01% |
230
-290
| -56% | -$20.3K |
2020 Q4
6 quarters
|
|
649
Boise Cascade
BCC
$2.53B
| $15K | ﹤0.01% |
260
-360
| -58% | -$26.6K |
2020 Q4
6 quarters
|
|
650
Bio-Rad Laboratories Class A
BIO
$10.4B
| $15K | ﹤0.01% |
30
-60
| -67% | -$31.2K |
2020 Q4
6 quarters
|
|
Similar funds
TF
HA
Fieldpoint Private Securities's Q2 2022 Portfolio in Review
As of Q2 2022, Fieldpoint Private Securities held 1,793 positions worth $344M, down 29% from $485M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Fieldpoint Private Securities withdrew a net $78.3M in Q2 2022, closing 244 positions and reducing 1,081 holdings. Its most notable exit was State Street SPDR S&P Dividend ETF, an estimated $911K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 36% a quarter earlier, followed by Technology and Financials.
Against the trend, Fieldpoint Private Securities opened a new position in WisdomTree US MidCap Dividend Fund worth $3.48M.
- Fieldpoint Private Securities's largest Q2 2022 buy was WisdomTree US MidCap Dividend Fund: 89,302 shares worth $3.48M.
- Fieldpoint Private Securities added most to iShares International Select Dividend ETF in Q2 2022, an estimated $7M increase.
- Fieldpoint Private Securities's biggest Q2 2022 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $3.61M.
- Fieldpoint Private Securities fully exited State Street SPDR S&P Dividend ETF in Q2 2022, selling an estimated $911K.
- Fieldpoint Private Securities's ten largest holdings make up 23% of its $344M portfolio in Q2 2022.
- Fieldpoint Private Securities opened 93 new positions and closed 244 in Q2 2022.
- Fieldpoint Private Securities's portfolio value fell 29% quarter-over-quarter to $344M.
Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.